Back
Novartis AG Vs. Akero Therapeutics Industry Stock Comparison
Sell
45
NVS
Novartis AG
Last Price:
$97.09
Seasonality Move:
-2.4%
Sell
32
AKRO
Akero Therapeutics
Last Price:
$29.35
Seasonality Move:
-9.11%
Sell
45
Novartis AG (NVS)
is a Sell
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVS] share price is $97.11. The Score for NVS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
NVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $29.34. The Score for AKRO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $97.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $29.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
NVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.58 | Sell |
Relative Strength Index (14 RSI): | 28.12 | Sell |
Chaikin Money Flow: | 575307 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.81 - 104.37) | Sell |
Bollinger Bands (100): | (104.41 - 117.41) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 45.72 | Sell |
Chaikin Money Flow: | 761403 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.2 - 31.7) | Sell |
Bollinger Bands (100): | (26.09 - 31.31) | Buy |
NVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 97.96 | Sell |
20-day SMA: | 101.17 | Sell |
50-day SMA: | 106.4 | Sell |
200-day SMA: | 106.33 | Sell |
8-day EMA: | 98.2 | Sell |
20-day EMA: | 100.59 | Sell |
50-day EMA: | 104.83 | Sell |
200-day EMA: | 106.54 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.33 | Buy |
20-day SMA: | 30.54 | Sell |
50-day SMA: | 30.81 | Sell |
200-day SMA: | 25.92 | Buy |
8-day EMA: | 29.44 | Sell |
20-day EMA: | 30.1 | Sell |
50-day EMA: | 30.09 | Sell |
200-day EMA: | 27.83 | Buy |
Novartis AG Earnings Growth & NVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
Novartis AG Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |